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ABSTRACT - Background: Dyslipidemia occurs in approximately 70% of all liver transplant (LT) 
recipients, and no prior control studies have demonstrated any dietary intervention to change 
it. Aim: To analyze the effects of a dietary intervention on the lipid profile of dyslipidemic LT 
recipients. Methods: All LT recipients with dyslipidemia on clinical follow-up were enrolled. 
Anthropometric evaluation, food history, body composition (bioimpedance) and assessment 
of basal metabolism through indirect calorimetry were performed. Patients met with a 
dietitian and an individualized diet based on estimate of basal metabolism and consisting 
of 25% of the total energy value in total fat and <200 mg/day of cholesterol was prescribed. 
Total cholesterol (TC), HDL-cholesterol (HDL), LDL-cholesterol (LDL), triglycerides (TG) and 
anthropometric measures were measured at baseline and six months after intervention. 
Results: Fifty-thee out of 56 patients concluded follow-up; age was 59±10 years; 29 were men 
(51.8%). The analysis pre- and post-intervention were, respectively: TC 238.9±30 and 165.1±35, 
p<0.001; LDL 154±33 and 90±29, p<0.001; and TG 168 (IQR=51-200) and 137 (IQR=94-177), 
p=<0.001. They were all modified at six months following intervention. At baseline, none of 
the patients had normal TC, and only 12 (22.7%) had optimal/near optimal LDL. Following 
dietary intervention, 45 patients (84.9%) reached normal TC and 50 (94.4%) had optimal/near 
optimal LDL. HDL and anthropometric measures were not modified. Conclusions: Dietary 
counseling with prescription of individualized diet based on estimate of basal metabolism 
through indirect calorimetry was able to manage dyslipidemia in most LT recipients; so, all 
dyslipidemic LT recipients must be enrolled on a dietary program.
RESUMO - Racional: A dislipidemia ocorre em aproximadamente 70% de todos os pacientes 
transplantados de fígado em acompanhamento ambulatorial. Não há relato prévio de qualquer 
intervenção dietética que houvesse controlado a dislipidemia nesse grupo de pacientes. 
Objetivo: Analisar os efeitos de uma intervenção dietética no perfil lipídico de pacientes 
transplantados hepáticos dislipidêmicos em acompanhamento ambulatorial. Métodos: 
Foram incluídos todos os pacientes adultos transplantados hepáticos com dislipidemia e em 
acompanhamento ambulatorial em nossa instituição. Avaliação antropométrica, anamnese 
alimentar, composição corporal (bioimpedância) e cálculo do metabolismo basal (calorimetria 
indireta) foram realizados. Pacientes foram atendidos por uma nutricionista e uma dieta 
individualizada baseada no metabolismo basal e consistindo de 25% do valor energético 
em gorduras totais e menos de 200 mg/dia de colesterol foi prescrita. Colesterol total (CT), 
HDL-colesterol (HDL), LDL-colesterol (LDL), triglicerídeos (TG) e medidas antropométricas 
foram medidos antes do início da dieta, sendo repetidos seis meses após o início da 
intervenção dietética. Resultados: Cinquenta e três pacientes concluíram o seguimento e 
tinham idade 59±10 anos e 29 eram homens (51,8%). CT pré-intervenção=238,9±30; pós-
intervenção=165,1±35, p<0.001; LDL pré-intervenção=154±33; pós-intervenção=90±29, 
p<0.001 e TG pré-intervenção=168, IQR=151-200; pós-intervenção=137, IQR=94-177, 
p=<0.001 sofreram modificações significativas seis meses após a intervenção. Antes do 
estudo, nenhum dos pacientes apresentava níveis séricos normais para o CT, e apenas 12 
pacientes (22,7%) tinham níveis séricos ótimo ou quase ótimos para o LDL. Seis meses após 
o início da intervenção, 45 pacientes (84,9%) alcançaram níveis séricos normais de CT e 50 
(94,4%) níveis séricos ótimos ou quase ótimos de LDL. Os níveis séricos de HDL e as medidas 
antropométricas não sofreram modificações significativas. Conclusões: Aconselhamento 
dietético com prescrição de dieta individualizada baseada no cálculo do metabolismo basal 
mostrou-se efetivo no manejo da dislipidemia em pacientes transplantados hepáticos em 
seguimento ambulatorial. Assim, todos os pacientes transplantados hepáticos com dislipidemia 
devem ser incluídos em um programa de intervenção dietética sob orientação de nutricionista.
Correspondence: 
Marcio F. Chedid
E-mail: marciochedid@hotmail.com
Financial source: Fundo de Incentivo à 
Pesquisa (FIPE), Grupo de Pesquisa e Pós-
Graduação, Hospital de Clínicas de Porto 
Alegre, RS, Brasil.
Conflicts of interest: none
Received for publication: 24/05/2016
Accepted for publication: 13/09/2016
DESCRITORES - Transplante hepático. 
Dislipidemia. Dieta. Orientação nutricional.
ABCDDV/1252
INTRODUCTION
Liver transplantation (LT) is the standard of care in the treatment of patients suffering from acute and chronic end-stage liver disease and selected primary and metastatic cancer to the liver14. It is the second most 
performed type of organ transplant, surpassed only by kidney transplantation6. A 
significant improvement in quality of life and survival is expected following it, and 
LT recipients may reach up to 80% 5-year survival 7, 13, 28.
As immediate results of LT have improved, death from cardiovascular causes 
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has acquired a prominent role, for which metabolic syndrome 
represents an important risk factor21. It consists of several 
metabolic disorders, including visceral obesity, diabetes 
mellitus, dyslipidemia and hypertension12. Up to a third 
of patients undergoing TH become obese in the period of 
three years after surgery22. Besides that, differently from 
cirrhotic patients who commonly present with low serum 
lipid levels, a high percentage of liver transplants have 
abnormally elevated serum lipid4. Dyslipidemia, one of the 
components of metabolic syndrome, is present in up to 70% 
of all LT recipients17, and constitutes an important risk factor 
for post-transplant cardiovascular morbidity and mortality29. 
Dietary management represents an area with a great 
research potential16,25. The potential benefits of dietary 
intervention would include prevention of cardiovascular 
death and increase satisfaction and quality of life of liver 
transplant patients15, 25. No prior studies have demonstrated 
any dietary intervention that could effectively control 
dyslipidemia in these patients. 
The aim of this study was to verify the effects of a 
dietary intervention comprising dietary counseling with 
prescription of an individualized diet on the lipid profile 
of post-liver transplantation patients with dyslipidemia.
METHODS
This research was approved by Institutional Research 
Board from Hospital de Clínicas de Porto Alegre and carried 
out according to the ethical guidelines outlined by The 
Transplantation Society and have involved no commercial 
transactions or other unethical practices in obtaining donor 
organs. 
Population
All liver transplant patients using whole liver graft 
from a deceased donor at our Institution between 2002 
and July, 2014 and followed for dyslipidemia were enrolled. 
Inclusion criteria were being at least two months after LT, 
age >18, and suffering from dyslipidemia without the use 
of lipid-lowering drugs. Pregnant patients, drug users, 
and patients suffering from any physical or neurological 
disability that prevented them from undergoing nutritional 
or anthropometric evaluation or obtaining the informed 
consent were not included. Dietary consultations and data 
collection were performed at the Clinical Research Center 
of the Federal University of  Rio Grande do Sul from March, 
2014 to May, 2015 by the first author of this study (Pinto, AS).
Logistics
Patients were followed for the period of six months, 
in three meetings (baseline-, 3rd- and 6th-month meetings). 
Identification, clinical, anthropometric and biochemical data 
were recorded. Besides, the self-report about the practice 
of physical exercises were also included in each patient’s 
record. Serum levels of total cholesterol (TC), HDL-cholesterol 
(HDL), LDL-cholesterol (LDL) and triglycerides (TG) were 
measured. Biochemical exams were analyzed at baseline 
(pre-intervention) and in the last meeting (post-intervention).
 Anthropometric evaluation, food history with the 
use of a 24 h recall, body composition analysis through 
bioimpedance and resting energetic expenditure though 
indirect calorimetry were recorded at baseline. After the 
settlement of resting energy expenditure, the total calorie 
value of the diet was calculated for each patient.   
Diet review, anthropometric evaluation and 24 h 
recall were performed on 3rd and 6th month meetings. 
Bioimpedance and indirect calorimetry also were repeated 
on 6th month meeting. 
Anthropometric evaluation
It was performed by a single researcher and included: 
weight, height, body mass index, circumference waist, neck 
circumference, triceps skinfold and subscapular skinfold. 
According to body mass index in kg/m² for adults were classified 
as: low weight <18,5; eutrophic: 18,5-24,9; overweight: ≥25; 
pre-obese: 25,0 to 29,9; obese I: 30,0 to 34,9; obese II: 35,0 
to 39,9; and obese III: ≥ 40,0. Elderly (aged <65 years-old) 
were classified as following: low weight: ≤22; eutrophic: 
>22 and < 27; and overweight: ≥2730.
Circumferences were measured with a non-flexible 
tape-measure. The circumference waist was measured at 
the midpoint between the lower costal margin and the 
iliac crest. It was established as cutting point for increased 
cardiovascular risk circumference waist, equal or above 94 
cm for men and 80 cm for women. Men with a circumference 
waist, above 102 cm and women  above 88 cm were classified 
as possessing a very increased cardiovascular risk9. Neck 
circumference was measured with the patient facing the 
evaluator and the tape positioned in the middle of the neck 
between the mean cervical spine and the anterior neck (for 
men possessing a laryngeal prominence, measurements 
were performed an inch below laryngeal prominence). The 
neck circumference cut off levels for classifying individuals 
as overweight were 37 cm for men and 34 cm for women. 
For obesity, neck circumference measures were 39.5 cm or 
higher for men and 36.5 cm or higher for women3. 
For measuring skinfolds, a Cescorf® adipometer was 
utilized. Measurements were performed on the right side of 
the body, with the subject resting at orthostatic position. For 
the triceps skinfold, the anatomical reference was the midpoint 
between the lateral projection of the acromion process of 
the scapula and the lower edge of the olecranon. The fold 
was vertically pinched to the longitudinal axis, in the rear 
arm24. Regarding the subscapular skinfold, the anatomical 
reference was 2 cm below the lower angle of the scapula. 
The adipometer was placed in the natural fold direction, 
obliquely downward and laterally to the longitudinal axis 
of the body at a 45° angle24.
Food history
Food history was performed through of 24 h recall, 
aiming to quantify all the food ingested at home in a 
regular day. It was assessed before baseline meeting and 
also before the two subsequent meetings (at 3rd and 6th 
follow-up months) 11. 
Evaluation of body composition
Bioimpedance
The patients were told to fast for 8 h before the 
procedure and to abstain from performing any physical 
activity and from alcohol and caffeine on the 24 h preceding 
the exam. Patients were also told to avoid heavy meals for 
at least 4 h before the test. They should not wear watches, 
armbands, earrings or necklaces during the test. A body 
composition analyzer, model Bodystat® 1500, was utilized. 
This method employed four little electrodes attached to 
their right hand and fist, and to the right ankle and foot. 
As standard, the bioimpedance measures were performed 
on the right side of the body19. The device was connected 
to the two pairs of electrodes and a low-voltage current 
was passed through the body, measuring the electrical 
resistance and reactance19. Similarly, the lean body mass, 
fat body mass, basal metabolic rate and total body water 
measures were obtained.
Indirect calorimetry (IC)
The indirect calorimetry is a non-invasive method 
which determines the energy needs and the rate of substrate 
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RESULTS
Fifty-three of all 56 patients concluded the study (two 
patients were lost to follow-up and the remaining patient died 
during the study period). Mean age was 59±10.10 years. There 
were 29 men (51.8%) and 27 women (48.2%). Mean time after 
LT was 46.5 months. The most common associated conditions 
were hypertension (n=29,  51.8%) and type 2 diabetes (n=25, 
44.6%); 25 (44.6%) were obese; 35 (62.5%) had sedentary 
lifestyle; 24 (42.9%) were on steroid therapy; 17 (30.4%) were 
on diuretic therapy; 8 (14.3%) were on beta-blockers use; 47 
(83.9%) were on tacrolimus treatment; 37 (66.1%) were on 
mycophenolate use; and 33 (58.9%) were on antihypertensive 
drug therapy (Table 1).
TABLE 1 - General features of the patients post-liver transplantation
Features Mean Standard Deviation
 Age (years) 56 59.05 ± 10.10
Gender
Female
Male
29 (51.8%)
27 (48.2%)
Marital status
Single
Married
Others
12 (21.4%)
28 (50%)
16 (28.6%)
LT Indication
Cirrhosis
Hepatitis C
Liver cancer
Others
40 (71.4%)
39 (69.6%)
21 (37.5%)
17 (30.5%)
Time of LT
0 to 2 years
2 to 4 years
4 or + years
17 (30.4%)
12 (21.4%)
27 (48.2%)
Drug therapy
Tacrolimus
Cyclosporine
Azathioprine
Mycophenolate
Prednisone
Antihypertensive
Vitamin D
Calcium
Insulin
Others
47 (83.9%)
3 (5.4%)
1 (1.8%)
37 (66.1%)
9 (16.1%)
33 (58.9%)
9 (16.1%)
14 (25%)
17 (30.4%)
42 (75%)
LT=liver transplantation
At baseline, 38 patients (67.9%) did not practice any 
physical activity, and 18 patients (32.2 %) exercised once or 
twice a week. At the end of the follow-up six months, 25 (47.2%) 
kept on a sedentary lifestyle and 28 (52.8%) performed some 
degree of physical activity. 
Mean total pre-intervention resting energy expenditure 
was 1533.16±290.7 kcal. The mean post-intervention resting 
energy expenditure was 1504±275.5 kcal (p=0.142). The 
distribution of the resting energy expenditure of each patient is 
displayed in Figure 1. Mean total energy value of the prescribed 
diet based on the patients’ resting energy expenditure was 
1853.57±218.2 kcal.
At the end of the six follow-up months, there was a 
statistically significant reduction to levels considered clinically 
normal for mean TC levels, mean LDL levels and median TG levels 
for the study population (Table 2). Pre-intervention means TC 
was 238.9±30, and post-intervention mean TC was 165.1±35 
(p<0.001). Pre-intervention mean LDL was 154±33, and post-
intervention mean LDL was 90±29 (p<0.001). Pre-intervention 
median TG was 168 (IQR=51-200), and post-intervention 
median TG was 137 was (IQR=94-177, p=<0.001). HDL was 
not modified (Table 2). 
utilization from the volume of oxygen consumption and the 
carbon dioxide production, obtained through analysis of 
air inhaled and exhaled by the lungs2. In patients with liver 
diseases, it is suggested that other factors may be involved 
in the basal metabolism alterations as a result of the chronic 
liver disease or the provided immunosuppressive treatment10. 
Assessment of the resting energy metabolism relative to 
a standard is performed based on the basal metabolism 
comparison measured by the standard method with the 
predictive formulas13. The basal metabolic was measured in 
a thermoneutral environment through indirect calorimetry 
(Metabolic Gas Analyzer VO 2000, Software Aerograph 
Breeze, Medical Graphics – Cardiorespiratory Diagnostic 
Systems), after a fasting period of at least 8 h. The system 
was calibrated according to before each measurement. The 
oxygen consumption and the carbon dioxide production 
were measured with a patient in supine position during 25 
min (including the initial time of 5 min).
Biochemistry evaluation
Blood lipid profile included serum levels of TC, HDL, 
LDL and TG, being measured at baseline (pre-intervention) 
and in the last meeting (post-intervention).
Dietary intervention
Dietary counseling was individualized considering 
the needs of each patient. The dietary regimen consisted 
of detailed description of the food replacements, times 
and daily amounts in household measures. Calorie needs 
were based on the resting energy expenditure obtained by 
the standard method for each patient plus +35 kcal/kg/
day for early LT recipients and +30 kcal/kg/day for late LT 
recipients23. The individualized diet was prescribed following 
recommendations of specific guidelines for prevention of 
atherosclerosis, and consisted of 25% of the energy value 
in total fat, ≤7% of the total energy value in saturated fat 
and <200 mg/day of cholesterol27. 
The diet and the dietary counseling were considered 
effective in those patients who reached a TC reduction to 
less than 200 mg/dl, TG less than 150 mg/dl, LDL less than 
130 mg/dl and HDL increase to serum levels higher than 
60 mg/dl.
Statistical analysis 
Association of dietary intervention to each TC, LDL, HDL 
and TG was evaluated through univariate analysis. Qualitative 
variables were compared using chi-square test. Quantitative 
variables were submitted to a normality test (Shapiro-
Wilk). Quantitative variables with normal distribution were 
presented as mean and standard deviation, and compared 
through paired t-test. Quantitative variables with asymmetric 
distribution were presented in median and quartiles, and 
compared through Wilcoxon Signed-rank Test. p<0.05 was 
considered as statistically significant. 
Potential confounding factors to the effect of diet 
on TC, LDL, HDL and TG were analyzed through univariate 
analyses. All potential confounding factors associated with 
improvement in any of the lipid parameters (p<0.1) were 
evaluated together with the effect of dietary intervention 
on TC, LDL, HDL and TG through the model Estimations 
Generalized Equations. In this analysis, the covariance 
matrix with robust estimator was used, an unstructured 
working correlation matrix and a normal distribution or 
gamma with identity or logarithmic link function when 
needed. Confidence intervals (95% CI) were calculated as 
needed. Data were analyzed using SPSS - version 18 (IBM 
Company, USA).
OriginAl Article
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FIGURE 1 - Pre-intervention resting energy expenditure: 
distribution as calculated by indirect calorimetry
TABLE 2 - Pre- and post-diet lipid profile 
Parameter Before After p value
TC¹ 238.83 ± 30.14 165.07 ± 35 < 0.001
LDL¹ 153.80 ± 33.08 89.91 ± 28.94 < 0.001
HDL² 44.50 [31.8; 55.8] 41.0 [33.0; 56.5] = 0.302
TG² 167.5 [151.2; 200] 137.0 [94.0; 177] < 0.001
Data with normal distribution are expressed in mean ± standard deviation and 
data with asymmetric distribution are expressed as median (interquartile range). 
1-Paired t-test; 2- Wilcoxon test; TC=total cholesterol; LDL=low-density lipoprotein; 
HDL=high-density lipoprotein; TG=triglycerides.
At baseline, none of the patients had desirable serum 
TC levels (Table 4). After intervention, 45 out of all 53 patients 
(84.9%) had normal TC. Before intervention, only 12 patients 
(22.7%) had optimal or near optimal LDL levels. After intervention, 
50 patients (94.4%) had optimal or near optimal serum LDL. 
Additionally, there was a four-time increase in the amount of 
patients presenting with normal levels following intervention 
(Table 3).
TABLE 3 - Distribution of pre- and post-diet lipid profile 
according (stratified by serum levels)  
Lipid profile Before, n (%) After, n (%)
TC
Desirable (<200)
Borderline (200-239)
High risk (<240)
0
28 (52.8)
25 (47.2)
45 (84.9)
6 (11.3)
2 (3.77)
LDL
Optimal (<100)
Near optimal (100-129)
Borderline (130-159)
High (>160)
3 (5.7)
9 (17)
18 (34)
24(45.3)
32(60.4)
18 (34)
3 (5.7)
0
TG
Normal (<150)
Borderline (150-199)
High (200-499)
Very high (>500)
7 (13.2)
32(60.4)
13 (24.5)
1 (1.9)
28 (52.8)
16 (30.2)
8 (15.1)
0
Stratifying per gender, similar results were obtained (Table 
4). Both men and women were classified as overweight (body 
mass index ≥25 kg/m²) pre- and post-intervention (Table 4). 
For the circumference waist both pre- and post-intervention, 
men were considered as being at an increased cardiovascular 
risk and the women in very increased cardiovascular risk. Basal 
metabolic rate and resting energy expenditure were higher in 
the men than in the women (Table 4). Except for the subscapular 
skinfold, anthropometric measures (weight, body mass index, 
waist circumference, neck circumference, triceps skinfold, 
subscapular skinfold and body composition (lean body mass, 
fatty body mass, total body weight and basal metabolic rate did 
not show significant changes following intervention (Table 5). 
TABLE 4 - Lipid profile and nutritional status stratified by gender 
Parameter Gender Before After p value
TC¹ MF
238.33 ±26.71
239.34 ±33.86
160.77 ±37.25
169.53 ±32.58
< 0.001
< 0.001
LDL¹ M F 
157.09 ±32.35
150.37 ±34.12 
84.22 ±28.58
95.81 ±28.67
< 0.001
< 0.001
HDL² MF
44.00[29.0; 53.5]
48.0[34.0; 60.0]
40.0[33.0; 51.0]
46.0[33.0; 58.0]
0.106
0.920
TG² MF
162.0[149.5;192.0]
168.0[157.0;220.0] 
150.0[105.0;178.0]
123.5[88.5; 177.0]
0.025
< 0.001
Weight¹ MF
83.79 ±18.03
71.83 ±14.33
83.22 ±17.23
73.35 ±13.03
0.264
0.058
BMI¹ MF
28.11 ±5.42
28.49 ±5.07
27.92 ±5.18
29.10 ±4.43
0.268
0.067
WC¹ MF
99.98 ±13.96
90.64 ±11.25
99.86 ±13.37
92.47 ±11.49
0.807
0.021
TSF¹ MF
11.73 ±6.15
20.83 ±6.83
10.44 ±7.30
20.85 ±7.94
0.282
0.977
SSF¹ MF
19.63 ±8.82
23.04 ±9.78
16.64 ±8.56
22.20 ±9.16
0.004
0.326
NC¹ MF
40.19 ±4.13
34.61 ±3.07
39.67 ±3.64
34.84 ±3.07
0.012
0.290
LBM¹ MF
70.56 ±5.92
61.25 ±6.90
70.55 ±4.96
59.88 ±6.29
0.997
0.038
FBM¹ MF
29.43 ±5.92
38.23 ±6.94
29.23 ±5.35
40.02 ±6.17
0.817
0.027
TBW¹ MF
42.32 ±8.81
32.02 ±5.33
42.72 ±7.05
31.90 ±4.78
0.641
0.752
BMR¹ MF
1817.42 ±360.47
1359.62 ±252.07
1783.76 ±301.78
1364.54 ±242.62
 0.140
0.701
REE¹ MF
1651.46 ±320.94
1379.62 ±210.48
1606.13 ±295.08
1393.35 ±206.06
0.021
0.178
Data with normal distribution are expressed in mean ± standard deviation and data 
with asymmetric distribution are expressed as median (interquartile range). 1- Paired 
t-test; 2- Wilcoxon test; F=female; M=male; TC=total cholesterol; LDL=low-density 
lipoprotein; HDL=high-density lipoprotein; TG=triglycerides; BMI=body mass 
index; WC=waist circumference; TSF=triceps skinfold; SSF=subscapular skinfold; 
NC=neck circumference; LBM=lean body mass; FBM=fat body mass; TBW=total 
body water; BMR=basal metabolic rate; REE=resting energy expenditure.=
TABLE 5 - Pre- and post-diet nutritional status of the patients 
Before,
Mean ± Std. Dev
After
Mean ±Std. Dev p value
 Weight (kg) 78.05 ±17.28 78.48 ±16.00 0.357
BMI (kg/m²) 28.29 ± 5.21 28.49 ±4.82 0.286
WC (cm) 95.50 ±13.45 96.32 ±12.93 0.072
TSF (mm) 16.10 ±7.89 15.44 ±9.19 0.348
SSF (mm) 21.27 ±9.36 19.31 ±9.20 0.004
NC (cm) 37.50 ±4.59 37.35 ±4.14 0.303
LBM (%) 66.43 ±7.73 65.44 ±7.75 0.236
FBM (%) 33.35 ±7.60 34.41 ±7.88 0.209
TBW (L) 37.61 ±8.72 37.53 ±8.12 0.753
BMR (kcal) 1609.39 ±377.53 1582.54 ±344.763 0.255
REE(kcal) 1533.16 ±290.7 1504.0 ±275.48 0.142
Paired t-test. BMI=body mass index; WC=waist circunference; TSF=triceps 
skinfold; SSF=subscapular skinfold; NC=neck circumference; LBM=lean body 
mass; FBM=fat body mass; TBW=total body water; BMR=basal metabolic rate; 
REE=resting energy expenditure
The effect of dietary intervention on TC levels was not 
influenced by any of the following factors: use of tacrolimus, 
use of mycophenolate, use of prednisone, use of any anti-
hypertensive drug, vitamin D therapy, calcium therapy, diabetes 
on insulin therapy, obesity, sedentary life style, diabetes, and 
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diuretic therapy, and practice of physical exercise. The effect 
of the diet on TG levels was influenced by use of insulin 
(p<0.001) and use of diuretics (p=0.003), and also by use of 
antihypertensive medication (p=0.026). The effect of the dietary 
intervention on LDL levels received influence from the use of 
prednisone (p=0.015). The time frame after transplantation 
(0-2 years, 2-4 years, 4 or + years) did not influence the effect 
of the diet intervention on lipid profile (TC, TG, LDL). 
DISCUSSION
This study evaluated the results of a dietary intervention 
consisting of dietary counseling with prescription of individualized 
diet to a cohort of 53 liver transplant patients suffering from 
dyslipidemia. The diet was based on accurate resting energy 
expenditure values estimated by indirect calorimetry, the gold 
standard method for basal metabolism measurements. This 
intervention yielded significant improvements on lipid profile 
(TC, LDL and TG) for this cohort. The improvements on TC, LDL 
and TG were statistically significant, “normalizing” mean TC, 
mean LDL and median TG for this cohort. At baseline, none of 
the patients had desirable TC levels. After intervention, 45 out 
of all 53 patients (84.9%) had normal TC. Before intervention, 
only 12 patients (22.7%) had optimal or near optimal LDL 
levels. After intervention, 50 patients (94.4%) had optimal or 
near optimal serum LDL. Additionally, there was a four-time 
increase in the amount of patients presenting with normal 
levels following intervention. HDL profile was not improved 
by dietary intervention. 
A recent study evaluated 23 LT recipients (16 females and 
7 males) with BMI >27 kg/m² and suffering from dyslipidemia. 
Patients were evaluated before and after six months of dietary 
intervention based on a diet recommended by the American 
Heart Association. Following dietary intervention, TC levels were 
reduced (p<0.05). However, when the data was stratified by 
gender, both TC and LDL were reduced only for male patients. 
There were no significant reductions on TG and HDL for this 
population20. Another study evaluated the effect of a 12-month 
diet with total fat below 30% and cholesterol below 300 mg/
day on the lipid profile of 46 kidney transplant recipients. A 
significant weight loss and BMI reduction along with concurrent 
improvements in TC levels were obtained. No significant change 
on TG was obtained14. 
Physical activity levels of liver transplant patients usually 
are significantly inferior to those from general population7. A 
study evaluating 136 patients after liver transplantation verified 
that most patients did not go back to work and/or remained 
on a sedentary life style after this procedure26. The current 
study showed that there was an increase in practice of physical 
activities from 32.2% to 50 % during study period. Similarly, 
another study evaluating liver transplant patients showed that 
51% of the patients reported to engage in some physical activity, 
with more than 27% of the population performing more than 
150 minutes per week16. It is know that the exercise capacity 
is limited before and after LT, suggesting that combining 
dietary intervention and physical activity protocols would help 
improving both anthropometric parameters and lipid profile. 
Immunosuppressive drugs have been associated to post-
transplant metabolic syndrome and to an increased cardiovascular 
risk for liver transplant patients10,16. Death from cardiovascular 
cause has acquired a prominent role in LT recipient population, 
for which metabolic syndrome also represents an important 
risk factor21. Although yielding significant improvement on lipid 
profile, the dietary intervention evaluated in the present study 
was not effective in improving anthropometric parameters, 
with most patients remaining overweight after the end of this 
study. Other studies also show similar results1,18. It remains 
unclear whether the physical exercise levels were not enough 
for improving anthropometric parameters or the observation 
period was too short for obtaining significant weight loss.   
This improvement in lipid profile may have happened 
secondarily to dietary counseling along with the diet. Besides, 
the fact that the dietary counseling has been individualized and 
resting energy expenditure was measured by indirect calorimetry 
reinforces the importance of having a diet prescribed in an 
individualized and accurate fashion.
TC levels did not suffer any effect of potential confounders. 
In other words, TC reduction levels was influenced only by the 
dietary intervention. For TG levels, diabetes on insulin therapy 
was a confounding factor, potentially influencing the effect of 
the dietary intervention on serum TG levels. Similar findings 
were reported elsewhere1. Use of diuretics also may have 
influenced the effect of the diet on improvements of TG levels. 
However, prior studies reported LT recipients having their lipid 
profile worsened by the use of diuretics and beta blockers. 
In addition to promote an increase in TG, diuretics may also 
cause glucose intolerance, raising the risk for diabetes5. The 
effect of this dietary intervention on LDL might have been 
influenced by use of prednisone. No prior study had reported 
similar results. Instead, the studies show that prednisone 
is an immunosuppressive drug which promotes metabolic 
disorders, mainly dyslipidemia, increasing the lipid levels and 
not reducing them8.    
As a limitation to the present study stands out the absence 
of a control group. Although improvements on TC, LDL and 
TG could have occurred secondary to other factors other than 
dietary intervention, the main confounding factors were analyzed 
by the Generalized Estimating Equations model. Thus, it seems 
that the majority of the improvements on lipid profile can be 
attributed to the dietary intervention. Another limitation of this 
study is its short follow-up period. However, considering the 
improvement to the lipid profile occurred in a short time span, 
it is likely that a longer study period would reflect on further 
important improvements, including anthropometric ones.
CONCLUSION
Dietary counseling with prescription of individualized 
diet based on calculated resting energy expenditure by indirect 
calorimetry was able to manage dyslipidemia in most LT 
recipients evaluated in this study. We suggest all dyslipidemic 
LT recipients be enrolled on a dietary program. 
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